Position in ZTS
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$431,555,511
-$15,671,426 QoQ
Shares Held
3,650,753
+2.7% QoQ
Ownership
0.871%
of shares outstanding
% of Portfolio
0.10%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 93.1068193328883.ToString("F0")%
Shared 0.ToString("F0")%
None 6.8931806671116895.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Legal & General Group Plc holds $884,912,076 across 47 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (48.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
3,650,753 | $431,555,511 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,872,811 | $116,649,065 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
186,794 | $110,765,104 | |
| 4 | VTRS |
Viatris Inc
|
3,838,534 | $51,858,592 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
380,589 | $50,138,793 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
709,808 | $16,985,705 | |
| 7 | ALKS |
Alkermes plc.
|
380,722 | $13,462,329 | |
| 8 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,411,199 | $13,434,613 |
All Filings in ZTS
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $431,555,511 | 3,650,753 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $447,226,937 | 3,554,498 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $499,806,292 | 3,415,844 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $543,480,914 | 3,484,969 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $539,097,028 | 3,274,200 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $540,456,894 | 3,317,111 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $684,696,313 | 3,504,434 | Shares | Defined | 2025-02-28 | |
| 2024-06-30 | $575,703,768 | 3,320,857 | Shares | Defined | 2025-05-29 | |
| 2024-03-31 | $580,031,743 | 3,427,881 | Shares | Defined | 2025-05-29 | |
| 2023-12-31 | $683,982,576 | 3,465,484 | Shares | Defined | 2025-05-29 | |
| 2023-09-30 | $609,178,964 | 3,501,431 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $630,181,312 | 3,659,377 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $614,366,490 | 3,691,219 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $530,766,729 | 3,621,745 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $565,268,133 | 3,811,910 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $686,209,116 | 3,992,141 | Shares | Defined | 2022-08-22 | |
| 2022-03-31 | $745,235,638 | 3,951,618 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $882,959,594 | 3,618,242 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $701,905,597 | 3,615,461 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $632,245,494 | 3,392,603 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $478,730,537 | 3,039,945 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $510,368,733 | 3,083,799 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $504,708,247 | 3,051,994 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $427,137,234 | 3,116,880 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $370,975,001 | 3,152,137 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||